Abstract: The present invention relates to a kit suitable for preparing a sustained release composition, in particular for preparing a sustained release composition comprising spermatozoa embedded within an alginate matrix.

Abstract: The present invention provides combination therapy that includes an KRASG12C inhibitor, such as or a pharmaceutically acceptable salt thereof, and one or more additional pharmaceutically active agents, particularly for the treatment of cancers. The invention also relates to pharmaceutical compositions that contain an KRASG12C inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers.

Abstract: A portable apparatus for use by first responders comprises at least one receiver configured to receive input from at least one medical sensor; a display device configured to display first response guidance to a user; user input device configured to receive input from the user; and processing circuitry configured to process the input from the at least one medical sensor and the input from the user; select the first response guidance to be displayed to the user via the display device, the selecting of the first response guidance comprising: estimating a status of the human subject based on the input from the at least one sensor, and selecting at least one item of first response guidance from a plurality of stored items of first response guidance based on the estimated status; wherein the first response guidance comprises at least one action to be performed by the user.

Abstract: A tetradentate chelating monoquinoline derivative with a structure as shown in formula (I) is able to specifically chelate redox active metal ions like copper ions that are dis-regulated in neurodegenerative diseases (Alzheimer's disease, Huntington's disease, Parkinson's disease, and amyotrophic lateral sclerosis), or copper accumulation disease like Wilson's disease. The binding constants of these derivatives for zinc are 6-10 orders of magnitude below that ones for copper, and these derivatives have a good capability of reducing an oxidative stress. The method for preparing the derivative is simple and the derivatives have good application prospects in manufacturing drugs for neurodegenerative diseases and diseases related to disorder of copper metabolism.

Abstract: A tetradentate chelating monoquinoline derivative with a structure as shown in formula (I) is able to specifically chelate redox active metal ions like copper ions that are dis-regulated in neurodegenerative diseases (Alzheimer's disease, Huntington's disease, Parkinson's disease, and amyotrophic lateral sclerosis), or copper accumulation disease like Wilson's disease. The binding constants of these derivatives for zinc are 6-10 orders of magnitude below that ones for copper, and these derivatives have a good capability of reducing an oxidative stress. The method for preparing the derivative is simple and the derivatives have good application prospects in manufacturing drugs for neurodegenerative diseases and diseases related to disorder of copper metabolism.

Abstract: The invention is dedicated to a colored latex comprising a mixture of an uncolored initial latex and at least one initial aqueous dispersion of at least one pigment being under the form of particles, wherein the particles of the pigment(s) are water-insoluble, and an amount of at least 90% of the particles of the one or more pigment(s) have a particle size of 370 nm or less, in the initial aqueous dispersion. The invention also relates to a process for preparing such colored latex and an ophthalmic lens coated with a layer of such colored latex.

Abstract: The invention relates to dual molecules formed from coupling products complying with the formula wherein A represents a residue of molecule with anti-malarial activity, Y1 and Y2, represent a linear or branched alkylene chain at C1 to C5, or either Y1 or Y2 is absent, U is an amine, amide, sulphonamide, carboxyl, ether or thioether function, said function linking Y1 and Y2, Z1 and Z2, represent a linear arylene or alkylene, or either Z1 or Z2 is absent, or Z1+Z2 together represent a cyclic or polycyclic structure including the junction carbons Ci and Cj, R1 and R2, represent a hydrogen atom or a functional group capable of increasing the hydrosolubility of the dual molecule, Rx and Ry form a cyclic peroxide with 4 to 8 chain links, Cj being one of the peaks of said cyclic peroxide, or -Rx or Ry is a cyclic peroxide with 4 to 8 chain links, which may comprise 1 or 2 additional oxygen atoms in the cyclic structure, and one or more substituents R3, identical or different, at least one R3 representing a hal

Abstract: Aluminum sheet products having highly anisotropic grain microstructures and highly textured crystallographic microstructures are disclosed. The products exhibit improved strength and improved resistance to fatigue crack growth, as well as other advantageous properties such as improved combinations of strength and fracture toughness. The sheet products are useful for aerospace and other applications, particularly aircraft fuselages.

Abstract: The invention relates to dual molecules formed from coupling products complying with the formula wherein A represents a residue of molecule with anti-malarial activity, Y1 and Y2, represent a linear or ramified alkylene chain at C1 to C5, with the possibility of either Y1 or Y2 being absent, U is an amine, amide, sulphonamide, carboxyl, ether or thioether function, said function linking Y1 and Y2, Z1 and Z2, represent a linear arylene or alkylene, with the possibility of either Z1 or Z2 being absent, or Z1+Z2 together represent a polycyclic structure including the junction carbons Ci and Cj, R1 and R2, represent a hydrogen atom or a functional group capable of increasing the hydrosolubility of the dual molecule, Rx and Ry form a cyclic peroxide with 4 to 8 chain links, Cj being one of the peaks of said cyclic peroxide, or Rx or Ry is a cyclic peroxide with 4 to 8 chain links, which may comprise 1 or 2 additional oxygen atoms in the cyclic structure, and one or more substituents R3, identical or

Abstract: The invention relates to dual molecules formed from coupling products complying with the formula wherein A represents a residue of molecule with anti-malarial activity, Y1 and Y2, represent a linear or ramified alkylene chain at C1 to C5, with the possibility of either Y1 or Y2 being absent, U is an amine, amide, sulphonamide, carboxyl, ether or thioether function, said function linking Y1 and Y2, Z1 and Z2, represent a linear arylene or alkylene, with the possibility of either Z1 or Z2 being absent, or Z1+Z2 together represent a polycyclic structure including the junction carbons Ci and Cj, R1 and R2, represent a hydrogen atom or a functional group capable of increasing the hydrosolubility of the dual molecule, Rx and Ry form a cyclic peroxide with 4 to 8 chain links, Cj being one of the peaks of said cyclic peroxide, or Rx or Ry is a cyclic peroxide with 4 to 8 chain links, which may comprise 1 or 2 additional oxygen atoms in the cyclic structure, and one or more substituents R3, identical or differe

Abstract: Abrasion resistant coating compositions based on silane hydrolyeates and aluminium compounds and corresponding abrasion and shock resistant coated articles The invention relates to a hardenable composition for an abrasion resistant coating comprising the following constituents: A—an epoxytrialkoxysilane hydrolysate, B—a hydrolysate of a silane having formula (I) where T1 and T2 each react to give a OH group on hydrolysis and Z1 and Z2 are unreactive organic groups, C—collcidal silica, D—a specific aluminium catalyst, E—optionally, an organic solvent with a boiling point between 70° C. and 140° C., and to corresponding coated articles, which can have nor-reflective treatments.

Abstract: Methods are provided for diagnosing and/or characterizing chronic immune disease activity in a subject. In the subject methods, a sample is obtained from a subject suspected of having or known to have a chronic immune disease. The sample is then assayed for the presence of low molecular actin fragments. The assay results are used to diagnose the presence of chronic immune disease activity and/or characterize chronic immune disease activity in the subject, e.g. to confirm an initial chronic immune disease diagnosis, to determine the stage of the disease, to monitor disease progression, to predict disease attacks, and the like. Also provided by the subject invention are kits for practicing the methods.

Abstract: The present invention relates to an organic glass ophthalmic lens having an impact-resistant primer layer based on a polyurethane latex and its manufacturing process.